ArticleDiabetes, obesity & metabolism2022

Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease.

Jinnie J Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.